by Michael Roub | Aug 24, 2026 | Exit Planning, Healthcare, M&A Strategy
Most healthcare owners think about valuation in terms of revenue or a multiple they heard at a conference. Buyers think differently. Understanding that gap and closing it before you go to market is one of the most consequential things you can do to protect your...
by Michael Roub | Aug 10, 2026 | Healthcare
The structure of your deal matters as much as the price. How the transaction is built determines your tax exposure, your liability after closing, and how much of the purchase price you actually keep. Most healthcare sellers spend the bulk of their time negotiating...
by Michael Roub | Aug 3, 2026 | Healthcare
Most healthcare owners start too late. The decisions you make 18 to 24 months before a sale often determine your outcome more than anything you do in the final weeks. That gap between a reactive exit and a strategic one comes down to preparation, not timing or luck....
by Michael Roub | Jul 27, 2026 | Healthcare
The letter of intent is not a handshake. It is a document that sets the terms, tone, and trajectory of your entire transaction. Most sellers treat it as a preliminary step, a starting point before the real negotiation begins. That assumption is expensive. The moment...
by Michael Roub | Jul 20, 2026 | Healthcare
Valuation stops being abstract the moment you receive a letter of intent, start fielding acquisition calls, or begin planning your exit. That number on paper becomes a real decision with real consequences. And for most healthcare owners, it comes with a jarring...
